病例报告：急性心肌梗死登记处C反应蛋白血液滤过治疗非ST段抬高型急性冠状动脉综合征病例系列
Case Report: C-reactive protein apheresis in non-ST-elevation ACS-case series from the C-reactive protein apheresis in Acute Myocardial Infarction Registry.
作者信息
Torzewski J, Mattecka S, Esposito F, Heigl F, Fiedler J, Sheriff A
机构信息
Cardiovascular Center Oberallgaeu-Kempten, Clinic Association Allgaeu, Kempten, Germany.
Pentracor GmbH, Hennigsdorf, Germany.
出版信息
Front Cardiovasc Med. 2024 Aug 15;11:1401566. doi: 10.3389/fcvm.2024.1401566. eCollection 2024.
C-reactive protein (CRP) apheresis has been introduced in ST-elevation myocardial infarction and cardiogenic shock. Here, we describe a first-in-man application in non-ST-elevation acute coronary syndrome (NSTE-ACS). Seven NSTE-ACS patients with high CRP levels (range 14.2-154 mg/L) were treated with CRP apheresis. Treatment was well-tolerated. Patients were discharged in good clinical condition.
C反应蛋白（CRP）吸附疗法已应用于ST段抬高型心肌梗死和心源性休克。在此，我们描述其在非ST段抬高型急性冠状动脉综合征（NSTE-ACS）中的首例人体应用。7例CRP水平较高（范围为14.2 - 154mg/L）的NSTE-ACS患者接受了CRP吸附治疗。治疗耐受性良好。患者出院时临床状况良好。
Zotero 插件